omeprazole has been researched along with bromodeoxyuridine in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 4 (80.00) | 18.2507 |
2000's | 1 (20.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Reuben, M; Sachs, G; Scott, D; Zampighi, G | 1 |
Flogerzi, B; Halter, F; Peskar, BM; Schmassmann, A; Tarnawski, A; Varga, L | 1 |
Fukamachi, H; Ichinose, M; Ishihama, S; Kakei, N; Kurokawa, K; Matsushima, M; Miki, K; Shimizu, M; Tatematsu, M; Yahagi, N | 1 |
Chen, D; De Backer, T; HÃ¥kanson, R; Van Nieuwenhove, Y; Willems, G | 1 |
Smith, AM; Watson, SA | 1 |
5 other study(ies) available for omeprazole and bromodeoxyuridine
Article | Year |
---|---|
Cell isolation and genotoxicity assessment in gastric mucosa.
Topics: Animals; Bromodeoxyuridine; Cell Separation; DNA; Gastric Mucosa; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Necturus; Omeprazole; Rats; Rats, Inbred Strains | 1990 |
Influence of acid and angiogenesis on kinetics of gastric ulcer healing in rats: interaction with indomethacin.
Topics: Animals; Bromodeoxyuridine; Drug Combinations; Female; Fibroblast Growth Factor 2; Gastric Acid; Gastric Mucosa; Gastrins; Gastroscopy; Indomethacin; Kinetics; Neovascularization, Pathologic; Omeprazole; Prostaglandins; Rats; Rats, Wistar; Stomach Ulcer; Wound Healing | 1995 |
Effect of CCK-B/gastrin receptor antagonist on pepsinogen-producing cells during omeprazole treatment.
Topics: Animals; Benzodiazepines; Bromodeoxyuridine; Gastric Mucosa; Immunohistochemistry; Male; Omeprazole; Pepsinogens; Rats; Rats, Wistar; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; RNA, Messenger; Stomach | 1995 |
Gastrin stimulates epithelial cell proliferation in the oesophagus of rats.
Topics: Animals; Bromodeoxyuridine; Cell Division; Epithelial Cells; Esophagus; Gastrins; Male; Mitotic Index; Omeprazole; Rats; Rats, Sprague-Dawley; Sodium Chloride; Stomach | 1998 |
Hypergastrinemia promotes adenoma progression in the APC(Min-/+) mouse model of familial adenomatous polyposis.
Topics: Adenoma; Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Animals; Bromodeoxyuridine; Cancer Vaccines; Colorectal Neoplasms; Cytoskeletal Proteins; Diphtheria Toxoid; Disease Models, Animal; Disease Progression; Female; Gastrins; Gene Expression Regulation; Heterozygote; Immunization; Intestinal Mucosa; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Omeprazole; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; RNA, Messenger; Survival Rate | 2001 |